Capsule AI Visibility Market Strategy Report - Online Pharmacies

Answer Capsule

Capsule holds a small but highly positive position in AI-generated online pharmacy recommendations for October 2026. The LLM Authority Index benchmark shows Capsule with 12.31% valid recommendation coverage, an 8.10% top-three rate, and a 1.56% rank-one rate across 642 qualified observations. Capsule's clearest win is framing quality: a net sentiment score of 0.8817, among the highest in the category, with zero negative mentions. Its clearest weakness is scale and placement, since presence sits at 14.49% while category leader Amazon Pharmacy reaches 55.45% coverage and a 34.11% rank-one rate. The clearest opportunity is converting Capsule's strong positive framing into higher shortlist placement in the Brand Recommendation cluster, where all qualified observations currently sit.

Who This Report Is For

This report is for Capsule's marketing, growth, and category strategy leaders who need to understand how AI search surfaces recommend online pharmacies, where Capsule appears in those recommendations, and where the brand is being displaced by competitors at the decision moment.

Report Card

Executive Summary

Questions This Section Answers

• Where does Capsule rank in AI pharmacy recommendations, and how large is the gap to the category leaders?
• Why is Capsule's sentiment score strong while its shortlist placement remains weak?

Capsule is visible in AI pharmacy recommendations but under-recommended relative to the category leaders. Across 642 qualified observations in October 2026, Capsule recorded 93 mentions, 79 valid recommendations, and a 12.31% valid recommendation coverage rate. That places Capsule eighth in the ten-brand tracked set, behind Amazon Pharmacy, CVS Pharmacy, Walgreens, Express Scripts, GoodRx Care, Cost Plus Drugs, and Honeybee Health.

The framing story is stronger than the placement story. Capsule recorded 82 positive mentions, 11 neutral mentions, and zero negative mentions, producing a net sentiment score of 0.8817. That is the second-highest net sentiment score among the ten tracked brands, behind only Honeybee Health at 0.92. AI systems that mention Capsule frame it positively almost every time.

Placement is where Capsule loses ground. Capsule's top-three rate is 8.10% and its rank-one rate is 1.56%, meaning the brand appears in a top-three shortlist in roughly one of every twelve qualified observations and is named first in roughly one of every sixty-four. Amazon Pharmacy, by comparison, holds a 46.88% top-three rate and a 34.11% rank-one rate. CVS Pharmacy holds a 25.55% top-three rate and a 4.98% rank-one rate.

The strongest cluster signal for Capsule is the Brand Recommendation cluster, which is the only cluster with qualified data in the October 2026 benchmark. Capsule's 79 valid recommendations and 12.31% coverage all sit inside that cluster. The Pricing & Value and Multi-Brand Comparison clusters returned no qualified observations at the benchmark level, so Capsule's position in pricing and head-to-head comparison prompts cannot be assessed from the public data.

The strongest platform signal for Capsule is Copilot, where Capsule recorded a 30.67% valid recommendation coverage rate and a 4.00% rank-one rate. The weakest platform signal is Perplexity, where Capsule recorded a 3.28% coverage rate and no rank-one placements. Google AI Overviews produced Capsule's largest single-platform recommendation volume, with 22 valid recommendations and a 12.50% coverage rate.

The clearest gap is the distance between Capsule's positive framing and its shortlist placement. Capsule is being described well but is not being named first. That gap, not a visibility problem, is the central strategic issue in this report.

What Capsule Is Winning

Questions This Section Answers

• What does Capsule's zero-negative mention record and net sentiment score say about how AI systems frame the brand?
• On which platform does Capsule convert mentions into recommendations best, and how does that compare with rivals like CVS and Walgreens?
• How does Capsule's rank-one rate compare with smaller competitors such as Cost Plus Drugs and Honeybee Health?

Capsule's strongest evidence-backed win is framing quality. With 82 positive mentions, 11 neutral mentions, and zero negative mentions, Capsule's net sentiment score of 0.8817 is the second-highest in the tracked set. No other brand in the category combines this level of positive framing with a zero-negative record except Honeybee Health and PillPack (Amazon Pharmacy), both of which have smaller mention bases.

Capsule's second win is Copilot performance. On Copilot, Capsule recorded a 30.67% valid recommendation coverage rate, an 18.67% top-three rate, and a 4.00% rank-one rate across 75 observations. That coverage rate is higher than Capsule's overall 12.31% coverage by a wide margin, and it exceeds Walgreens' Copilot coverage of 26.67%, while remaining behind CVS Pharmacy's Copilot coverage of 44.00%. Copilot appears to be the platform where Capsule's recommendation signal is strongest relative to the field.

Capsule's third win is a narrow but meaningful rank-one pocket. Capsule recorded 10 rank-one recommendations in October 2026, giving it a 1.56% rank-one rate. That rate exceeds Cost Plus Drugs at 1.40% and Honeybee Health at 0.31%, while sitting below Walgreens at 2.18% and Express Scripts at 1.87%. Capsule's rank-one rate sits mid-pack among the smaller brands, which is a meaningful signal given its lower presence rate.

These wins are real but narrow. Capsule does not hold a dominant position on any single platform or cluster. The brand's strength is concentrated in framing quality and a modest Copilot advantage, not in category leadership.

Where Capsule Has the Clearest AI Visibility Gaps

Questions This Section Answers

• Why is Capsule's recommendation gap driven by low presence rather than poor conversion efficiency?
• How far behind is Capsule in top-three and rank-one placements compared with Amazon Pharmacy and CVS Pharmacy?
• Which platforms and clusters leave Capsule's pricing and comparison performance unmeasurable from the public data?

Capsule's clearest gap is recommendation conversion relative to presence. Capsule's raw mention presence rate is 14.49%, and its valid recommendation coverage is 12.31%. That is a conversion ratio of roughly 85%, which sounds efficient, but the absolute numbers are small. Capsule is mentioned in 93 of 642 qualified observations and recommended in 79. Amazon Pharmacy is mentioned in 602 and recommended in 356. The gap is not conversion efficiency; it is total presence in the prompts that matter.

The second gap is top-three placement. Capsule's top-three rate of 8.10% means the brand appears in a top-three shortlist in 52 of 642 qualified observations. Amazon Pharmacy appears in 301, CVS Pharmacy in 164, Walgreens in 84, Express Scripts in 88, and Cost Plus Drugs in 84. Capsule is being shortlisted less than a third as often as Walgreens and less than a fifth as often as CVS Pharmacy.

The third gap is rank-one placement. Capsule's rank-one rate of 1.56% translates to 10 first-position recommendations across 642 observations. Amazon Pharmacy holds 219, CVS Pharmacy 32, GoodRx Care 29, Walgreens 14, PillPack (Amazon Pharmacy) 13, and Express Scripts 12. Capsule is being named first less often than every major competitor except Honeybee Health and Optum. In a category where the first named option carries default-choice weight, this is the most commercially significant gap in Capsule's profile.

The fourth gap is platform concentration. Capsule's recommendation signal is heavily concentrated on Copilot and Google AI Overviews. On Perplexity, Capsule recorded only 2 valid recommendations and a 3.28% coverage rate. On Gemini, Capsule recorded 16 valid recommendations and a 17.58% coverage rate. On ChatGPT, Capsule recorded 6 valid recommendations and an 8.57% coverage rate. Capsule's presence on ChatGPT, the platform with the largest opportunity pool in the benchmark, is thin relative to competitors. CVS Pharmacy recorded 34 valid recommendations on ChatGPT, Walgreens 20, and Amazon Pharmacy 43.

The fifth gap is cluster coverage. All of Capsule's qualified observations sit in the Brand Recommendation cluster. The Pricing & Value and Multi-Brand Comparison clusters returned no qualified observations at the benchmark level, so Capsule's position in pricing and comparison prompts is not measurable from the public data. The October response mix included 107 pricing-analysis and 25 comparison-analysis answers, which suggests the underlying prompts exist even though they do not qualify into the public benchmark set. Capsule's performance in those prompt types is a known unknown.

Biggest Opportunity

Questions This Section Answers

• How can Capsule convert its strong framing into more top-three and rank-one placements in the Brand Recommendation cluster?
• Which platform coverage rates show where Capsule can gain shortlist placement without changing how AI systems describe the brand?

Capsule's biggest opportunity is converting its strong positive framing into higher shortlist placement in the Brand Recommendation cluster. Capsule is already being described positively by AI systems; the gap is that it is not being named first or second often enough. The brand's 0.8817 net sentiment score and zero negative mentions mean the framing layer is working. The placement layer is not.

The specific path is to increase Capsule's presence in the prompts that drive top-three and rank-one recommendations. Capsule's Copilot performance shows the brand can convert when it appears. The opportunity is to appear more often in the same prompt types across ChatGPT, Gemini, and Perplexity, where Capsule's coverage rates are 8.57%, 17.58%, and 3.28% respectively. Closing even part of that platform gap would move Capsule's top-three and rank-one rates without requiring a change in how AI systems frame the brand.

Competitive Landscape

Questions This Section Answers

• Where does Capsule sit in the tracked set on top-three rate, rank-one rate, and average recommended rank?
• How does Capsule's sentiment compare with higher-placement competitors like Amazon Pharmacy and CVS Pharmacy?

Amazon Pharmacy holds dominant recommendation-stage strength in the online pharmacy category, with CVS Pharmacy as the strongest challenger and a broad second tier beneath them. Capsule sits in the lower portion of that second tier, with strong framing but limited shortlist placement.

Average recommended rank covers rank-eligible recommendations only.

Capsule's position in the table shows a brand with mid-tier shortlist placement and top-tier framing. Its 8.10% top-three rate places it seventh of ten, ahead of PillPack, Honeybee Health, and Optum. Its 1.56% rank-one rate places it seventh as well. Its 2.94 average recommended rank is mid-pack, better than Walgreens, Express Scripts, Honeybee Health, and Optum, but behind Amazon Pharmacy, CVS Pharmacy, GoodRx Care, PillPack, and Cost Plus Drugs. Its 0.8817 sentiment score is second only to Honeybee Health.

Prompt Evidence

Copilot / Best Online Pharmacy Discovery & Evaluation Prompt: "What are the top 5 pharmacies?" Result: Capsule recorded a 30.67% valid recommendation coverage rate on Copilot, its strongest platform signal, with 23 valid recommendations and an 18.67% top-three rate.

Perplexity / Best Online Pharmacy Discovery & Evaluation Prompt: "Which is the most reliable online pharmacy?" Result: Capsule recorded only 2 valid recommendations on Perplexity, a 3.28% coverage rate, and no rank-one placements, making Perplexity Capsule's weakest platform.

ChatGPT / Best Online Pharmacy Discovery & Evaluation Prompt: "What is the best mail-order pharmacy?" Result: Capsule recorded 6 valid recommendations on ChatGPT, an 8.57% coverage rate, and no rank-one placements, well behind CVS Pharmacy's 34 valid recommendations on the same platform.

Google AI Overviews / Best Online Pharmacy Discovery & Evaluation Prompt: "Who are the big 3 pharmacies?" Result: Capsule recorded 22 valid recommendations on Google AI Overviews, a 12.50% coverage rate, and 5 rank-one placements, its largest single-platform recommendation volume.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map Capsule's prompt-level presence across ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode to identify which specific prompts drive top-three and rank-one placements and which do not.

Phase 2: Recommendation Readiness Plan Prioritize the prompt types where Capsule is mentioned but not shortlisted, and build a plan to move the brand from reference to recommendation in those prompts.

Phase 3: Owned Answer Layer Buildout Strengthen Capsule's owned pages and structured content so AI systems have clear, retrievable answers to the questions that drive pharmacy shortlists.

Phase 4: Citation / Authority Layer Development Develop the public evidence layer, including third-party sources, comparison pages, and authoritative references, that AI systems cite when forming pharmacy recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Capsule's coverage, top-three rate, rank-one rate, and sentiment month over month to measure whether the placement gap is closing.

Why This Matters

AI presence alone is not enough. Capsule is mentioned in 93 of 642 qualified observations and framed positively in 82 of those, but it is named first in only 10. The difference between being mentioned and being recommended first is the difference between being on the buyer's radar and being the buyer's default choice.

The next move is targeted correction of the prompt, page, and citation layers that determine where Capsule appears in AI-generated shortlists. The benchmark shows Capsule has the framing. The work is to convert that framing into placement.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Capsule in October 2026: (82 × 1 + 11 × 0 + 0 × -1) / 93 = 0.8817.

This matters because unclassified mention counts are misleading. A brand with 93 mentions and a 0.8817 sentiment score is in a very different position from a brand with 93 mentions and a 0.40 sentiment score. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility.

Capsule's 0.8817 sentiment score is a genuine strength. It means AI systems that mention Capsule frame it positively almost every time. The strategic question is not whether Capsule is framed well; it is whether that framing is converting into shortlist placement.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Capsule's AI recommendation visibility in the online pharmacy category for October 2026. It is not a client implementation case study.
2. The reporting window is October 2026, with comparisons to July 2026, August 2026, and September 2026 where the source data provides them.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The October 2026 benchmark began with 800 prompt-surface observations and produced 642 qualified observations after qualification. August 2026 contributed 596 qualified observations and September 2026 contributed 643.
5. Ten brands were tracked: Amazon Pharmacy, Capsule, Cost Plus Drugs, CVS Pharmacy, Express Scripts, GoodRx Care, Honeybee Health, Optum, PillPack (Amazon Pharmacy), and Walgreens.
6. One public high-intent cluster carried qualified data in October 2026: Best Online Pharmacy Discovery & Evaluation. The Pricing & Value and Multi-Brand Comparison clusters returned no qualified observations at the benchmark level.
7. Stage 0 extraction retained the query, AI/search surface, answer, brand outcome, recommendation placement, sentiment, and, where exposed, citations or attributable evidence sources.
8. A mention is counted when a tracked brand appears in a qualified observation. Capsule recorded 93 mentions in October 2026.
9. A valid recommendation is counted when a brand appears in a recommendation-shaped answer. Capsule recorded 79 valid recommendations in October 2026.
10. Brand-level percentages use the 642 qualified observations as the public denominator, not the 800 raw prompt-surface observations.
11. Average recommended rank covers rank-eligible recommendations only. Capsule's average recommended rank of 2.94 is based on its rank-eligible recommendations.
12. Limitations: The public benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone. The Pricing & Value and Multi-Brand Comparison clusters returned no qualified observations, so Capsule's position in pricing and comparison prompts cannot be assessed from the public data. The benchmark's source data includes modeled monetary metrics, which are excluded from this report.

See How AI Is Recommending Your Brand

The public benchmark shows where Capsule stands in AI-generated pharmacy recommendations. A company-level AI visibility audit maps the prompt, platform, competitor, and citation patterns behind those numbers into a prioritized strategy for closing the placement gap.